Postoperative chloride mmol/L · adults receiving intravenous fluids whilst undergoing any form of surgery
1 finding from 1 review
Stroke · patients with hypertension
Enalapril plus folic acid leads to lower stroke compared with enalapril (high certainty).
1 finding from 1 review
First unstable angina pectoris episode requiring hospitalisation · patients with hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause · patients with hypertension
Enalapril plus folic acid showed no clear difference in death from any cause compared with enalapril (high certainty).
1 finding from 1 review
Serious adverse event (cancer) · patients with hypertension
Enalapril plus folic acid showed no clear difference in serious adverse event (cancer) compared with enalapril (moderate certainty).
1 finding from 1 review
Myocardial infarction · patients with hypertension
Enalapril plus folic acid showed no clear difference in myocardial infarction compared with enalapril (moderate certainty).
1 finding from 1 review
All‐cause infant mortality at 6 months: risk ratios based on cumulative risk (%, adjusted for clustering) ‐ term infants · mortality and morbidity in term neonates
It is very uncertain whether neonatal vitamin A supplementation changes all‐cause infant mortality at 6 months: risk ratios based on… compared with control (very low certainty).
1 finding from 1 review
Infant Mortality at 6 Months · mortality and morbidity in term neonates
Neonatal vitamin A supplementation showed no clear difference in all‐cause infant mortality at 6 months: risk ratios based on… compared with control (high certainty).
1 finding from 1 review
Neonatal mortality · mortality and morbidity in term neonates
Neonatal vitamin A supplementation showed no clear difference in all‐cause neonatal mortality: risk ratios based on cumulative risk… compared with control (high certainty).
1 finding from 1 review
Adverse events during first 48‐72 hours post supplementation ‐ bulging fontanelle · mortality and morbidity in term neonates
Neonatal vitamin A supplementation leads to higher adverse events during first 48‐72 hours post supplementation ‐… compared with control (high certainty).
1 finding from 1 review
Vomiting · mortality and morbidity in term neonates
Neonatal vitamin A supplementation showed no clear difference in adverse events during first 48‐72 hours post supplementation ‐… compared with control (high certainty).
1 finding from 1 review
Adverse effects: diarrhoea 48 to 72 hours · mortality and morbidity in term neonates
Neonatal vitamin A supplementation showed no clear difference in adverse events during first 48‐72 hours post supplementation ‐… compared with control (low certainty).
1 finding from 1 review
Vitamin A deficiency · mortality and morbidity in term neonates
Neonatal vitamin A supplementation showed no clear difference in vitamin A deficiency (serum retinol < 0.70 micromol/L) at 6 weeks of… compared with control (high certainty).
2 findings from 1 review
Intervention not reported
Systolic BP ‐ Aliskiren 75 mg vs. placebo · primary hypertension
1 finding from 1 review
Intervention not reported
Systolic BP ‐ Aliskiren 150 mg vs. placebo · primary hypertension
1 finding from 1 review
Intervention not reported
Systolic BP ‐ Aliskiren 300 mg vs. placebo · primary hypertension
1 finding from 1 review
Intervention not reported
Systolic BP ‐ Aliskiren 600 mg vs. placebo · primary hypertension
1 finding from 1 review
Intervention not reported
Diastolic BP ‐ Aliskiren 75 mg vs placebo · primary hypertension
1 finding from 1 review
Intervention not reported
Diastolic BP ‐ Aliskiren 150 mg vs placebo · primary hypertension
1 finding from 1 review
Intervention not reported
Diastolic BP ‐ Aliskiren 300 mg vs placebo · primary hypertension
1 finding from 1 review